Savastano C P, Brito L A, Faria Á C, Setó-Salvia N, Peskett E, Musso C M, Alvizi L, Ezquina S A M, James C, Beales P, Lees M, Moore G E, Stanier P, Passos-Bueno M R
Centro de Pesquisa sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK.
Clin Genet. 2017 May;91(5):683-689. doi: 10.1111/cge.12823. Epub 2016 Jul 26.
Non-syndromic cleft lip with or without cleft palate (NSCL/P) is a prevalent, complex congenital malformation. Genome-wide association studies (GWAS) on NSCL/P have consistently identified association for the 1p22 region, in which ARHGAP29 has emerged as the main candidate gene. ARHGAP29 re-sequencing studies in NSCL/P patients have identified rare variants; however, their clinical impact is still unclear. In this study we identified 10 rare variants in ARHGAP29, including five missense, one in-frame deletion, and four loss-of-function (LoF) variants, in a cohort of 188 familial NSCL/P cases. A significant mutational burden was found for LoF (Sequence Kernel Association Test, p = 0.0005) but not for missense variants in ARHGAP29, suggesting that only LoF variants contribute to the etiology of NSCL/P. Penetrance was estimated as 59%, indicating that heterozygous LoF variants in ARHGAP29 confer a moderate risk to NSCL/P. The GWAS hits in IRF6 (rs642961) and 1p22 (rs560426 and rs4147811) do not seem to contribute to the penetrance of the phenotype, based on co-segregation analysis. Our data show that rare variants leading to haploinsufficiency of ARHGAP29 represent an important etiological clefting mechanism, and genetic testing for this gene might be taken into consideration in genetic counseling of familial cases.
非综合征性唇裂伴或不伴腭裂(NSCL/P)是一种常见的复杂先天性畸形。针对NSCL/P的全基因组关联研究(GWAS)一直确定1p22区域存在关联,其中ARHGAP29已成为主要候选基因。对NSCL/P患者进行的ARHGAP29重测序研究已发现罕见变异;然而,它们的临床影响仍不清楚。在本研究中,我们在188例家族性NSCL/P病例队列中,在ARHGAP29中鉴定出10个罕见变异,包括5个错义变异、1个框内缺失变异和4个功能丧失(LoF)变异。发现ARHGAP29的LoF变异存在显著的突变负荷(序列核关联检验,p = 0.0005),但错义变异不存在,这表明只有LoF变异促成NSCL/P的病因。估计外显率为59%,表明ARHGAP29中的杂合LoF变异赋予NSCL/P中度风险。基于共分离分析,IRF6(rs642961)和1p22(rs560426和rs4147811)的GWAS命中似乎对该表型的外显率没有贡献。我们的数据表明,导致ARHGAP29单倍体不足 的罕见变异代表了一种重要的腭裂病因机制,在家族性病例的遗传咨询中可能会考虑对该基因进行基因检测。